COVID‐19 and immunosuppressive therapy in dermatology

Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID‐19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Dermatol Ther
Главные авторы: Schwartz, Robert A., Pradhan, Swetalina, Murrell, Dedee F., Jafferany, Mohammad, Olisova, Olga Y., Lomonosov, Konstantin M., Lotti, Torello, Goldust, Mohamad
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Inc. 2020
Предметы:
Review Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435553/
https://ncbi.nlm.nih.gov/pubmed/32770592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dth.14140
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы